Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer
627 An innovative approach to improve bispecific T-cell engagers for solid tumor therapy
- 1HCW Biologics Inc. Miramar, FL, USA
- 2HCW Biologics Inc., Miramar, FL, USA
Related
- Bispecific VSV-G Engagers: A Platform for Cell-Type-Specific Delivery of Viral Vectors
- T-cell engagers in solid tumors: challenges and emerging strategies
- Case Report: CD20/BCMA bispecific CAR-T therapy for progressive multiple sclerosis
- 902 Reprogrammed regulatory T cells as cytotoxic effectors drive anti-tumor immunity under bispecific T cell engager therapy
- CD3-CSPG4 bispecific T cell engager: A novel platform for malignant melanoma therapy
BibTeX
@article{zhu2026innovative,
title = {{627 An innovative approach to improve bispecific T-cell engagers for solid tumor therapy}},
author = {Xiaoyun Zhu and Lijing You and Varghese George and Niraj Shrestha and Hamidreza Farzaneh and Crystal Gilkes and Natalia Valderrama and Alyssa Thompson and Lucas Gomez and Christian Echeverri and Peter R Rhode and Jack O Egan and Hing C Wong},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2026},
month = nov,
doi = {10.1136/jitc-2026-sitc2026.0627},
url = {https://doi.org/10.1136/jitc-2026-sitc2026.0627},
note = {CC BY},
}
RIS
TY - JOUR
TI - 627 An innovative approach to improve bispecific T-cell engagers for solid tumor therapy
AU - Xiaoyun Zhu
AU - Lijing You
AU - Varghese George
AU - Niraj Shrestha
AU - Hamidreza Farzaneh
AU - Crystal Gilkes
AU - Natalia Valderrama
AU - Alyssa Thompson
AU - Lucas Gomez
AU - Christian Echeverri
AU - Peter R Rhode
AU - Jack O Egan
AU - Hing C Wong
PY - 2026
DA - 2026/11/06
JO - Journal for ImmunoTherapy of Cancer
DO - 10.1136/jitc-2026-sitc2026.0627
UR - https://doi.org/10.1136/jitc-2026-sitc2026.0627
SN - 2051-1426
ER -